Laparoscopic mini-gastric bypass in patients age 60 and older

Peraglie, Cesare

doi:10.1007/s00464-015-4157-2

Cited by 30 publications

(11 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dr. Rutledge with 6,385 MGBs has had three operative deaths-the last in 2004. Peraglie found no deaths in his super-obese patients [23] and those age >60 [37].…”

Section: Discussionmentioning

confidence: 88%

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Deitel¹

2016

Austin J Surg

View full text Add to dashboard Cite

show abstract

“…Dr. Rutledge with 6,385 MGBs has had three operative deaths-the last in 2004. Peraglie found no deaths in his super-obese patients [23] and those age >60 [37].…”

Section: Discussionmentioning

confidence: 88%

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Deitel¹

2016

Austin J Surg

View full text Add to dashboard Cite

show abstract

“…Studies in which percentage total weight loss (%TWL) was reported in older people found loss of 17% to 38% after 1 to 6 years following gastric bypass and sleeve gastrectomy, and loss of 14% to 20% after adjustable gastric banding . For studies in which weight outcome was reported as percentage excess weight loss (%EWL), older persons undergoing RYGB or LSG lost 46% to 77% excess weight at 12 to 21 months, and 43% to 72% 2 to 6 years post‐operatively . After LAGB, studies reported %EWL of 14% to 36% at 1 year, and 35% to 48% at 5 years' follow‐up .…”

Section: Resultsmentioning

confidence: 99%

Treatment of obesity in older persons—A systematic review

Haywood

Sumithran

2019

Obesity Reviews

View full text Add to dashboard Cite

The study aims to systematically review the available evidence regarding weight loss interventions (lifestyle, surgical, and pharmacological) for obesity in adults aged over 60 years. A search of prospective, randomized studies took place in January 2018, on Medline (Web of Science) and PubMed databases. Search terms included the following: elderly, obese, hypocaloric, pharmacotherapy, and bariatric surgery. Abstracts were screened for eligibility. A total of 256 publications regarding lifestyle interventions were identified; of these, 69 studies were eligible. As no eligible studies were identified for pharmacotherapy or bariatric surgery, the search was broadened to include non-randomized studies. Four pharmacotherapy and 66 surgery studies were included. Lifestyle intervention had similar weight loss efficacy in older compared with younger people, with positive effects on a number of relevant outcomes, including physical function and cardiovascular parameters. There was little data regarding obesity pharmacotherapy in older persons. The available data for bariatric surgery indicate comparable weight loss and resolution of type 2 diabetes, with similar or slightly higher complication rates in older compared with younger people. Older age alone should not be considered a contraindication to intensive lifestyle or surgical intervention for obesity. There are insufficient data to guide clinical decisions regarding obesity pharmacotherapy in older people. Abstract] OR RCT [Title/Abstract] OR randomly [Title/Abstract] OR random [Title/Abstract]) #1 Search ((obesity [Title/Abstract] OR obese [Title/Abstract] OR "weight loss"[Title/Abstract] OR "weight reduction"[Title/ Abstract])) AND (elderly [Title/Abstract] OR older [Title/ Abstract] OR geriatric [Title/Abstract]) HAYWOOD AND SUMITHRAN 589

show abstract

“…T2DM remission rates were mostly more than 84% [18,[20][21][22][23][26][27][28][29] Table 2 details the summary of complications in the same studies. 9 studies reported 0% mortality in their series.…”

Section: Efficacy-weight Loss and Resolution Of T2dmmentioning

confidence: 98%

“…Remaining studies were retrospective cohort studies, some comparing MGB to RYGB [20,24,28] while others Peraglie studied a specific subset of patients: the super super obese cohort [17] and in another study, those aged more than 60 years old [27].…”

Section: Efficacy-weight Loss and Resolution Of T2dmmentioning

confidence: 99%

A Safe and Efficacious Alternative to Roux-en-Y Gastric Bypass for the Treatment of Morbid Obesity and Type 2 Diabetes - One Anastamosis / Mini Gastric Bypass

Tan

Park

Kim

et al. 2016

J Metab Bariatr Surg

View full text Add to dashboard Cite

Roux-en-y gastric bypass (RYGB) is currently used to treat obesity and metabolic syndrome. It is however technically challenging with a steep learning curve and long operating times. Laparoscopitc mini-gastric bypass (LMGB) is another surgical method that is acclaimed to achieve similar efficacy and yet safe with acceptable complication rates. We reviewed current literature on LMGB on its efficacy and safety profile. Comprehensive search of available literature using a combination of key words was performed, looking out for efficacy and safety end points. Efficacy end points include excess weight loss, change in body mass index (BMI), resolution of metabolic syndrome or T2DM remission. Safety end points include mortality and morbidity rates, short and long term complications. 18 studies were selected with a total of 9392 patients. Follow up range was from 1 year to 6 years with majority of studies achieving 57%-92% excess weight loss (%EWL) within 1 year. Remission of T2DM rates were mostly more than 84%. Several studies reported better %EWL and T2DM remission when compared to SG and RYGB. Overall mortality rate was 0.152%. Morbidity rates vary from 2.7%-12.5%. Some studies reported lower mortality and complication rates in LMGB when compared to SG and RYGB. In summary, MGB is a safe and effective metabolic-bariatric procedure in treating morbid obesity and T2DM. It should be considered an alternative to standard RYGB. Risk of bile reflux, marginal ulcer and anemia needs to be explained to the patient when counselling for such procedure.

show abstract

Laparoscopic mini-gastric bypass in patients age 60 and older

Abstract: LMGB can be safely performed with good weight loss in patients ≥60 years old, despite numerous comorbidities and previous abdominal operations.

Cited by 30 publications

References 43 publications

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Treatment of obesity in older persons—A systematic review

A Safe and Efficacious Alternative to Roux-en-Y Gastric Bypass for the Treatment of Morbid Obesity and Type 2 Diabetes - One Anastamosis / Mini Gastric Bypass

Contact Info

Product

Resources

About